<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Obstetrics and Gynecology</journal-id><journal-title-group><journal-title xml:lang="en">Obstetrics and Gynecology</journal-title><trans-title-group xml:lang="ru"><trans-title>Акушерство и гинекология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0300-9092</issn><issn publication-format="electronic">2412-5679</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">696026</article-id><article-id pub-id-type="doi">10.18565/aig.2025.156</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Exchange of Experience</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Обмен опытом</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Features of medical history of women with uterine fibroids</article-title><trans-title-group xml:lang="ru"><trans-title>Особенности анамнеза женщин с миомой матки</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0711-7896</contrib-id><name-alternatives><name xml:lang="en"><surname>Oboskalova</surname><given-names>Tatyana A.</given-names></name><name xml:lang="ru"><surname>Обоскалова</surname><given-names>Татьяна Анатольевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Med. Sci., Professor, Head of the Department of Obstetrics and Gynecology with a Course of Medical Genetics</p></bio><bio xml:lang="ru"><p>д.м.н., профессор, заведующая кафедрой акушерства и гинекологии с курсом медицинской генетики</p></bio><email>oboskalova.tat@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0828-0479</contrib-id><name-alternatives><name xml:lang="en"><surname>Sevostyanova</surname><given-names>Olga Yu.</given-names></name><name xml:lang="ru"><surname>Севостьянова</surname><given-names>Ольга Юрьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Med. Sci., Professor, Department of Obstetrics and Gynecology with a Course of Medical Genetics</p></bio><bio xml:lang="ru"><p>д.м.н., профессор кафедры акушерства и гинекологии с курсом медицинской генетики</p></bio><email>olsyava@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1321-6583</contrib-id><name-alternatives><name xml:lang="en"><surname>Koval</surname><given-names>Marina V.</given-names></name><name xml:lang="ru"><surname>Коваль</surname><given-names>Марина Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, Associate Professor, Department of Obstetrics and Gynecology with a Course of Medical Genetics</p></bio><bio xml:lang="ru"><p>к.м.н., доцент кафедры акушерства и гинекологии с курсом медицинской генетики</p></bio><email>marinakoval1203@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-8859-5229</contrib-id><name-alternatives><name xml:lang="en"><surname>Omarbekova</surname><given-names>Anastasia T.</given-names></name><name xml:lang="ru"><surname>Омарбекова</surname><given-names>Анастасия Талгатовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Teaching Assistant, Department of Anatomy, Topographic Anatomy</p></bio><bio xml:lang="ru"><p>ассистент кафедры анатомии, топографической анатомии</p></bio><email>kosova_1971@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Ural State Medical University, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Уральский государственный медицинский университет» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2025-11-30" publication-format="electronic"><day>30</day><month>11</month><year>2025</year></pub-date><issue>10</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>143</fpage><lpage>148</lpage><history><date date-type="received" iso-8601-date="2025-11-10"><day>10</day><month>11</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-11-10"><day>10</day><month>11</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, ООО «Бионика Медиа»</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/0300-9092/article/view/696026">https://journals.eco-vector.com/0300-9092/article/view/696026</self-uri><abstract xml:lang="en"><p><bold>Objective: </bold>To study the features of the family, obstetric and gynecological as well as somatic anamnesis of women with uterine fibroids.</p> <p><bold>Materials and methods:</bold> A retrospective study of 212 case reports (2022–2025) was conducted at the multidisciplinary hospital "RZhD-Medicine" (Yekaterinburg). The study group included 117 patients with uterine fibroids, while the control group included 95 patients without uterine fibroids. Exclusion criteria included pregnancy, postmenopause, and cancer.</p> <p><bold>Results:</bold> The group with a history of uterine fibroids more often included the following pathologies: adenomyosis, endometrial hyperplasia, hydrosalpinx, endometrial polyps, cervical cysts, grade 1 obesity and a positive family history of breast cancer. Age at menarche, number of pregnancies, miscarriages, abortions, and previous deliveries, including vaginal deliveries and cesarean sections, did not show statistically significant differences between the study and the control groups. Body mass index also did not differ significantly between the compared groups.</p> <p><bold>Conclusion:</bold> The identified clinical criteria confirm the similarity of individual elements in the pathogenesis of uterine myoma, emphasizing the importance of taking into account anamnestic data when examining patients, and also allow us to identify risk groups for the development of uterine leiomyomas.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Цель: </bold>Изучить особенности семейного, акушерско-гинекологического и соматического анамнеза женщин с миомой матки.</p> <p><bold>Материалы и методы: </bold>В многопрофильном стационаре «РЖД-медицина» (Екатеринбург) проведено ретроспективное исследование 212 историй болезни (2022–2025 гг.). Основная группа – 117 пациенток с миомой матки, группа сравнения – 95 пациенток без миомы матки. Критериями невключения выступили: беременность, постменопауза, онкологические заболевания.</p> <p><bold>Результаты: </bold>В группе с миомой матки в анамнезе чаще отмечаются: аденомиоз, гиперплазия эндометрия, гидросальпинксы, полипы эндометрия, кисты шейки матки, ожирение 1 степени и отягощенный семейный анамнез по раку молочной железы. Возраст менархе, количество беременностей, выкидышей, абортов и родов в анамнезе, в том числе самостоятельных родов или родоразрешений путем кесарева сечения, не имеют статистически значимых различий в группах с миомой матки и без нее. Индекс массы тела также не продемонстрировал достоверной разницы в сравниваемых группах.</p> <p><bold>Заключение: </bold>Выявленные анамнестические критерии подтверждают общность отдельных звеньев патогенеза миомы матки, акцентируют внимание врача на важности учета анамнестических данных при обследовании пациенток, а также позволяют выделить группы риска формирования лейомиомы матки.</p></trans-abstract><kwd-group xml:lang="en"><kwd>uterine leiomyoma</kwd><kwd>uterine fibroids</kwd><kwd>clinical and anamnestic risk factors</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>лейомиома матки</kwd><kwd>миома матки</kwd><kwd>клинико-анамнестические факторы риска</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Eyong E., Okon O.A. Large uterine fibroids in pregnancy with successtul caesarean myomectomy. Case Rep. Obstet. Gynecol. 2020; 2020: 8880296. https://dx.doi.org/10.1155/2020/8880296</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Al Sulaimani R., Machado L., Al Salmi M. Do large uterine fibroids impact pregnancy outcomes? Oman Med. J. 2021; 36(4): e292. https://dx.doi.org/10.5001/omj.2021.93</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Министерство здравоохранения Российской Федерации. Клинические рекомендации. Миома матки. М.; 2024. 23 с. [Ministry of Health of the Russian Federation. Clinical guidelines. Uterine fibroids. Moscow; 2024. 23 p. (in Russian)].</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Ahmad A., Kumar M., Bhoi N.R., Badruddeen, Akhtar J., Khan M.I. et al. Diagnosis and management of uterine fibroids: current trends and future strategies. J. Basic Clin. Physiol. Pharmacol. 2023; 34(3): 291-310. https://dx.doi.org/10.1515/jbcpp-2022-0219</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Aninye I.O., Laitner M.H. Uterine fibroids: assessing unmet needs from bench to bedside. J. Womens Health (Larchmt). 2021; 30(8): 1060-7. https://dx.doi.org/10.1089/jwh.2021.0280</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Бахмудова Е.А., Амирханова Ч.Р. Миома матки в современных реалиях: комплексный обзор. Вестник науки. 2024; 1(70): 670-3. [Bakhmudova E.A., Amirkhanova Ch.R. Uterine fibroids in modern realities: comprehensive review. Bulletin of science. 2024; 1(70): 670-3 (in Russian)].</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Абдикамалова К.М. Современное хирургическое лечение миомы матки. Endless Light in Science. 2024; 21: 8-11. [Abdikamalova K.M. Modern surgical treatment of uterine fibroids. Endless Light in Science. 2024; 21: 8-11 (in Russian)].</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Малышкина Д.А., Сотникова Н.Ю., Воронин Д.Н., Калинина А.Е., Годунова Е.М., Голубева М.В., Румянцева Е.В. Клинико-анамнестические факторы риска развития лейомиомы матки у женщин репродуктивного возраста. Гинекология. 2023; 25(2): 170-6. [Malyshkina D.A., Sotnikova N.Yu., Voronin D.N., Kalinina A.E., Godunova E.M., Golubeva M.V., Rumyanceva E.V. Clinical and anamnestic risk factors for the development of uterine leiomyoma in women of reproductive age: a case control study. Gynecology. 2023; 25(2): 170-6 (in Russian)]. https://dx.doi.org/10.26442/20795696.2023.2.202209</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Цхай В.Б., Бадмаева С.Ж., Наркевич А.Н., Цхай И.И., Михайлова А.В. Прогностическая модель для расчета вероятности возникновения рецидива миомы матки после оперативного вмешательства. Фундаментальная и клиническая медицина. 2021; 6(3): 64-70. [Tskhay V.B., Badmaeva S.Zh., Narkevich A.N., Tskhay I.I., Mikhaylova A.V. A predictive model for calculating the likelihood of recurrent uterine fibroids after surgical intervention. Fundamental and Clinical Medicine. 2021; 6(3): 64-70 (in Russian)]. https://dx.doi.org/10.23946/2500-0764-2021-6-3-64-70</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Дикарева Л.В., Уханова Ю.Ю., Малышева И.П., Белявская С.А., Гаджиева П.Х. Значение фетальной макросомии, ожирения и маркера апоптоза TRAIL как ранних предикторов формирования миомы матки. Астраханский медицинский журнал. 2021; 16(1): 66-73. [Dikareva L.V., Ukhanova Yu.Yu., Malysheva I.P., Belyavskaya S.A., Gadzhieva P.Kh. The importance of fetal macrosomy, obesity and TRAIL apoptosis marker as early predictors of uterine myoma formation. Astrakhan Medical Journal. 2021; 16(1): 66-73 (in Russian)]. https://dx.doi.org/10.17021/2021.16.1.66.73</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Кузнецова М.В., Согоян Н.С., Трофимов Д.Ю. Генетические маркеры лейомиом и предрасположенность к развитию и рецидивированию заболевания. Медицинский оппонент. 2021; 2(14): 12-7. [Kuznetsova M.V., Sogoyan N.S., Trofimov D.Yu. Leiomyoma’s genetic markers and a predisposition to disease development and recurrences. Medical Opponent. 2021; 2(14): 12-7 (in Russian)].</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Коваль М.В., Кудрявцева Е.В., Кондрашова Ю.К., Тагоев Ю.Ш. Генетика миомы матки. Сибирское медицинское обозрение. 2023; (6): 16-24. [Koval M.V., Kudryavtseva E.V., Kondrashova Yu.K., Tagoev Yu.Sh. Genetics of uterine fi broids. Siberian Medical Review. 2023; (6): 16-24 (in Russian)]. https://dx.doi.org/10.20333/25000136-2023-6-16-24</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Исанбаева Л.М. Некоторые иммунологические аспекты патогенеза миомы матки. Российский иммунологический журнал. 2021; 1: 53-5. [Isanbayeva L.M. Some immunological aspects of the pathogenesis of uterine fibroids. Russian Journal of Immunology. 2021; 1: 53-5 (in Russian)].</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Yang Q., Ciebiera M., Bariani M.V., Ali M., Elkafas H., Boyer T.G. et al. Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment. Endocr. Rev. 2022; 43(4): 678-719. https://dx.doi.org/10.1210/endrev/bnab039</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Ахметгалиев А.Р., Хайруллина Г.Р., Сахабетдинов Б.А., Сираева А.Р. Влияние питания на течение миомы тела матки. Вестник медицинского института «РЕАВИЗ». Реабилитация, Врач и Здоровье. 2023; 13(6): 92-5. [Akhmetgaliev A.R., Khayrullina G.R., Sakhabetdinov B.A., Siraeva A.R. Influence of nutrition on the course of uterine fibroids. Bulletin of the Medical Institute «REAVIZ». Rehabilitation, Doctor and Health. 2023; 13(6): 92-5 (in Russian)]. https://dx.doi.org/10.20340/vmi-rvz.2023.6.CLIN.9</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Liu Z., Jiang M., Wang T., Li F., Zhu Y. A cause-effect relationship between uterine diseases and breast cancer: a bidirectional Mendelian randomization study. Heliyon. 2024; 10(18): e38130. https://dx.doi.org/10.1016/j.heliyon.2024.e38130</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Zeldin J., Sandler D.P., Ogunsina K., O'Brien K.M. Association of fibroids, endometriosis, and gynecologic surgeries with breast cancer incidence and hormone receptor subtypes. Cancer Epidemiol. Biomarkers Prev. 2024; 33(4): 576-85. https://dx.doi.org/10.1158/1055-9965.EPI-23-1014</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>MacLean J.A. 2nd, Hayashi K. Progesterone actions and resistance in gynecological disorders. Cells. 2022; 11(4): 647. https://dx.doi.org/10.3390/cells11040647</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Qin H., Lin Z., Vásquez E., Luan X., Guo F., Xu L. Association between obesity and the risk of uterine fibroids: a systematic review and meta-analysis. J. Epidemiol. Community Health. 2021; 75(2): 197-204. https://dx.doi.org/10.1136/jech-2019-213364</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Brewster L.M., Haan Y., van Montfrans G.A. Cardiometabolic risk and cardiovascular disease in young women with uterine fibroids. Cureus. 2022; 14(10): e30740. https://dx.doi.org/10.7759/cureus.30740</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Samantaray S., Joshi N., Vasa S., Shibu S., Kaloni A., Parekh B. et al. Integrated bioinformatics reveals genetic links between visceral obesity and uterine tumors. Mol. Genet. Genomics. 2024; 299(1): 93. https://dx.doi.org/10.1007/s00438-024-02184-9</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Олимов Д.М., Усманова У.И. Роль неспецифического воспаления при ожирении. Экономика и социум. 2022; 4-3(95): 249-53. [Olimov D.M, Usmanova U.I. The role of non-specific inflammation in obesity. Ekonomika-socium. 2022; 4-3(95): 249-53 (in Russian)].</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Бабаева Н.И., Наделяева Я.Г., Данусевич И.Н., Лазарева Л.М., Егорова И.Ю., Аталян А.В., Сутурина Л.В. Факторы, ассоциированные с миомой матки у женщин репродуктивного возраста: кросс-секционное исследование. Acta Biomedica Scientifica. 2024; 9(4): 26-34. [Babaeva N.I., Nadeliaeva I.G., Danusevich I.N., Lazareva L.M., Egorova I.Yu., Atalyan A.V., Suturina L.V. Factors associated with uterine fibroids in women of reproductive age: a cross-sectional study. Acta Biomedica Scientifica. 2024; 9(4): 26-34 (in Russian)]. https://dx.doi.org/10.29413/ABS.2024-9.4.4</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Qu Y., Chen L., Guo S., Liu Y., Wu H. Genetic liability to multiple factors and uterine leiomyoma risk: a Mendelian randomization study. Front. Endocrinol. (Lausanne). 2023; 14: 1133260. https://dx.doi.org/10.3389/fendo.2023.1133260</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Муркамилов И.Т., Айтбаев К.А., Фомин В.В., Муркамилова Ж.А., Юсупова З.Ф., Юсупова Т.Ф., Юсупов Ф.А. Оценка биомаркеров воспаления и факторы риска сердечно-сосудистых заболеваний при избыточной массе тела и ожирении. Кардиоваскулярная терапия и профилактика. 2024; 23(3): 3733. [Murkamilov I.T., Aitbaev K.A., Fomin V.V., Murkamilova Zh.A., Yusupova Z.F., Yusupova T.F., Yusupov F.A. Assessment of inflammatory biomarkers and risk factors for cardiovascular diseases in overweight and obesity. Cardiovascular Therapy and Prevention. 2024; 23(3): 3733 (in Russian)]. https://dx.doi.org/10.15829/1728-8800-2024-3733</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Коненков В.И., Шевченко А.В., Королева Е.Г., Прокофьев В.Ф., Тимофеева Ю.С., Айдагулова С.В., Маринкин И.О. Баланс цитокинов, регулирующих активность воспаления, в сыворотке крови пациенток с лейомиомой. Акушерство и гинекология. 2024; 6: 84-90. [Konenkov V.I., Shevchenko A.V., Koroleva E.G., Prokofiev V.F., Timofeeva Yu.S., Aidagulova S.V., Marinkin I.O. Balance of serum cytokines regulating inflammatory activity in patients with leiomyoma. Obstetrics and Gynecology. 2024; (6): 84-90 (in Russian)]. https://dx.doi.org/10.18565/aig.2024.74</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Sefah N., Ndebele S., Prince L., Korasare E., Agbleke M., Nkansah A. et al. Uterine fibroids – causes, impact, treatment, and lens to the african perspective. Front. Pharmacol. 2023; 13: 1045783. https://dx.doi.org/10.3389/fphar.2022.1045783</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Адамян Л.В., Припутневич Т.В., Гаврилова Т.Ю., Григорян И.Э. Миома матки и микробиота эндометрия: имеется ли взаимосвязь? Проблемы репродукции. 2022; 28(6): 164-9. [Adamyan L.V., Priputnevich T.V., Gavrilova T.Yu., Grigorian I.E. Uterine fibroids and endometrial microbiota: is there a relationship? Russian Journal of Human Reproduction. 2022; 28(6): 164-9 (in Russian)]. https://dx.doi.org/10.17116/repro202228061164</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Zheng Q., Sun T., Li X., Zhu L. Reproductive tract microbiome dysbiosis associated with gynecological diseases. Front. Cell. Infect. Microbiol. 2025; 15: 1519690. https://dx.doi.org/10.3389/fcimb.2025.1519690</mixed-citation></ref></ref-list></back></article>
